Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Feb 1;361(Pt 3):681–688. doi: 10.1042/0264-6021:3610681

Oxidative stress inhibits caveolin-1 palmitoylation and trafficking in endothelial cells.

Marie-Odile Parat 1, Rafal Z Stachowicz 1, Paul L Fox 1
PMCID: PMC1222352  PMID: 11802799

Abstract

During normal and pathological conditions, endothelial cells (ECs) are subjected to locally generated reactive oxygen species, produced by themselves or by other vessel wall cells. In excess these molecules cause oxidative injury to the cell but at moderate levels they might modulate intracellular signalling pathways. We have investigated the effect of oxidative stress on the palmitoylation and trafficking of caveolin-1 in bovine aortic ECs. Exogenous H2O2 did not alter the intracellular localization of caveolin-1 in ECs. However, metabolic labelling experiments showed that H2O2 inhibited the trafficking of newly synthesized caveolin-1 to membrane raft domains. Several mechanisms potentially responsible for this inhibition were examined. Impairment of caveolin-1 synthesis by H2O2 was not responsible for diminished trafficking. Similarly, the inhibition was independent of H2O2-induced caveolin-1 phosphorylation as shown by the markedly different concentration dependences. We tested the effect of H2O2 on palmitoylation of caveolin-1 by the incorporation of [3H]palmitic acid. Exposure of ECs to H2O2 markedly inhibited the palmitoylation of caveolin-1. Comparable inhibition was observed after treatment of cells with H2O2 delivered either as a bolus or by continuous delivery with glucose and glucose oxidase. Kinetic studies showed that H2O2 did not alter the rate of caveolin-1 depalmitoylation but instead decreased the 'on-rate' of palmitoylation. Together these results show for the first time the modulation of protein palmitoylation by oxidative stress, and suggest a cellular mechanism by which stress might influence caveolin-1-dependent cell activities such as the concentration of signalling proteins and cholesterol trafficking.

Full Text

The Full Text of this article is available as a PDF (259.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam L., Bouvier M., Jones T. L. Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling. J Biol Chem. 1999 Sep 10;274(37):26337–26343. doi: 10.1074/jbc.274.37.26337. [DOI] [PubMed] [Google Scholar]
  2. Aoki T., Nomura R., Fujimoto T. Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res. 1999 Dec 15;253(2):629–636. doi: 10.1006/excr.1999.4652. [DOI] [PubMed] [Google Scholar]
  3. Berthiaume L., Resh M. D. Biochemical characterization of a palmitoyl acyltransferase activity that palmitoylates myristoylated proteins. J Biol Chem. 1995 Sep 22;270(38):22399–22405. doi: 10.1074/jbc.270.38.22399. [DOI] [PubMed] [Google Scholar]
  4. Chien A. J., Gao T., Perez-Reyes E., Hosey M. M. Membrane targeting of L-type calcium channels. Role of palmitoylation in the subcellular localization of the beta2a subunit. J Biol Chem. 1998 Sep 4;273(36):23590–23597. doi: 10.1074/jbc.273.36.23590. [DOI] [PubMed] [Google Scholar]
  5. Das K., Lewis R. Y., Scherer P. E., Lisanti M. P. The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. J Biol Chem. 1999 Jun 25;274(26):18721–18728. doi: 10.1074/jbc.274.26.18721. [DOI] [PubMed] [Google Scholar]
  6. Dietzen D. J., Hastings W. R., Lublin D. M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem. 1995 Mar 24;270(12):6838–6842. doi: 10.1074/jbc.270.12.6838. [DOI] [PubMed] [Google Scholar]
  7. Dunphy J. T., Greentree W. K., Manahan C. L., Linder M. E. G-protein palmitoyltransferase activity is enriched in plasma membranes. J Biol Chem. 1996 Mar 22;271(12):7154–7159. doi: 10.1074/jbc.271.12.7154. [DOI] [PubMed] [Google Scholar]
  8. Dupree P., Parton R. G., Raposo G., Kurzchalia T. V., Simons K. Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J. 1993 Apr;12(4):1597–1605. doi: 10.1002/j.1460-2075.1993.tb05804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fielding C. J., Bist A., Fielding P. E. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3753–3758. doi: 10.1073/pnas.94.8.3753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fra A. M., Williamson E., Simons K., Parton R. G. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8655–8659. doi: 10.1073/pnas.92.19.8655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galbiati F., Volonte D., Meani D., Milligan G., Lublin D. M., Lisanti M. P., Parenti M. The dually acylated NH2-terminal domain of gi1alpha is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. Palmitoylation of caveolin-1 is required for the recognition of dually acylated g-protein alpha subunits in vivo. J Biol Chem. 1999 Feb 26;274(9):5843–5850. doi: 10.1074/jbc.274.9.5843. [DOI] [PubMed] [Google Scholar]
  12. García-Cardeña G., Martasek P., Masters B. S., Skidd P. M., Couet J., Li S., Lisanti M. P., Sessa W. C. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem. 1997 Oct 10;272(41):25437–25440. doi: 10.1074/jbc.272.41.25437. [DOI] [PubMed] [Google Scholar]
  13. Glenney J. R., Jr Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem. 1989 Dec 5;264(34):20163–20166. [PubMed] [Google Scholar]
  14. Hess D. T., Patterson S. I., Smith D. S., Skene J. H. Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature. 1993 Dec 9;366(6455):562–565. doi: 10.1038/366562a0. [DOI] [PubMed] [Google Scholar]
  15. Jaakkola P., Mole D. R., Tian Y. M., Wilson M. I., Gielbert J., Gaskell S. J., von Kriegsheim A., Hebestreit H. F., Mukherji M., Schofield C. J. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001 Apr 5;292(5516):468–472. doi: 10.1126/science.1059796. [DOI] [PubMed] [Google Scholar]
  16. Kang Y. S., Ko Y. G., Seo J. S. Caveolin internalization by heat shock or hyperosmotic shock. Exp Cell Res. 2000 Mar 15;255(2):221–228. doi: 10.1006/excr.1999.4792. [DOI] [PubMed] [Google Scholar]
  17. Klausner R. D., Donaldson J. G., Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol. 1992 Mar;116(5):1071–1080. doi: 10.1083/jcb.116.5.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lawrence D. S., Zilfou J. T., Smith C. D. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J Med Chem. 1999 Dec 2;42(24):4932–4941. doi: 10.1021/jm980591s. [DOI] [PubMed] [Google Scholar]
  19. Li S., Couet J., Lisanti M. P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 1996 Nov 15;271(46):29182–29190. doi: 10.1074/jbc.271.46.29182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J. E., Hansen S. H., Nishimoto I., Lisanti M. P. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem. 1995 Jun 30;270(26):15693–15701. doi: 10.1074/jbc.270.26.15693. [DOI] [PubMed] [Google Scholar]
  21. Li S., Seitz R., Lisanti M. P. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem. 1996 Feb 16;271(7):3863–3868. [PubMed] [Google Scholar]
  22. Lisanti M. P., Scherer P. E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y. H., Cook R. F., Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol. 1994 Jul;126(1):111–126. doi: 10.1083/jcb.126.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lisanti M. P., Tang Z. L., Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol. 1993 Nov;123(3):595–604. doi: 10.1083/jcb.123.3.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Loisel T. P., Adam L., Hebert T. E., Bouvier M. Agonist stimulation increases the turnover rate of beta 2AR-bound palmitate and promotes receptor depalmitoylation. Biochemistry. 1996 Dec 10;35(49):15923–15932. doi: 10.1021/bi9611321. [DOI] [PubMed] [Google Scholar]
  25. Moffett S., Brown D. A., Linder M. E. Lipid-dependent targeting of G proteins into rafts. J Biol Chem. 2000 Jan 21;275(3):2191–2198. doi: 10.1074/jbc.275.3.2191. [DOI] [PubMed] [Google Scholar]
  26. Monier S., Dietzen D. J., Hastings W. R., Lublin D. M., Kurzchalia T. V. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 1996 Jun 17;388(2-3):143–149. doi: 10.1016/0014-5793(96)00519-4. [DOI] [PubMed] [Google Scholar]
  27. Parat M. O., Fox P. L. Palmitoylation of caveolin-1 in endothelial cells is post-translational but irreversible. J Biol Chem. 2001 Feb 13;276(19):15776–15782. doi: 10.1074/jbc.M006722200. [DOI] [PubMed] [Google Scholar]
  28. Patterson S. I., Skene J. H. Novel inhibitory action of tunicamycin homologues suggests a role for dynamic protein fatty acylation in growth cone-mediated neurite extension. J Cell Biol. 1994 Feb;124(4):521–536. doi: 10.1083/jcb.124.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Peterson T. E., Poppa V., Ueba H., Wu A., Yan C., Berk B. C. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res. 1999 Jul 9;85(1):29–37. doi: 10.1161/01.res.85.1.29. [DOI] [PubMed] [Google Scholar]
  30. Robinson L. J., Busconi L., Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem. 1995 Jan 20;270(3):995–998. doi: 10.1074/jbc.270.3.995. [DOI] [PubMed] [Google Scholar]
  31. Sargiacomo M., Scherer P. E., Tang Z., Kübler E., Song K. S., Sanders M. C., Lisanti M. P. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9407–9411. doi: 10.1073/pnas.92.20.9407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Scherer P. E., Tang Z., Chun M., Sargiacomo M., Lodish H. F., Lisanti M. P. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem. 1995 Jul 7;270(27):16395–16401. doi: 10.1074/jbc.270.27.16395. [DOI] [PubMed] [Google Scholar]
  33. Schmitt D., Shen Z., Zhang R., Colles S. M., Wu W., Salomon R. G., Chen Y., Chisolm G. M., Hazen S. L. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry. 1999 Dec 21;38(51):16904–16915. doi: 10.1021/bi991623w. [DOI] [PubMed] [Google Scholar]
  34. Schuppe-Koistinen I., Moldéus P., Bergman T., Cotgreave I. A. S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur J Biochem. 1994 May 1;221(3):1033–1037. doi: 10.1111/j.1432-1033.1994.tb18821.x. [DOI] [PubMed] [Google Scholar]
  35. Simionescu M., Simionescu N., Palade G. E. Biochemically differentiated microdomains of the cell surface of capillary endothelium. Ann N Y Acad Sci. 1982;401:9–24. doi: 10.1111/j.1749-6632.1982.tb25703.x. [DOI] [PubMed] [Google Scholar]
  36. Smart E. J., Graf G. A., McNiven M. A., Sessa W. C., Engelman J. A., Scherer P. E., Okamoto T., Lisanti M. P. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol. 1999 Nov;19(11):7289–7304. doi: 10.1128/mcb.19.11.7289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smart E. J., Ying Y. S., Conrad P. A., Anderson R. G. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol. 1994 Dec;127(5):1185–1197. doi: 10.1083/jcb.127.5.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Smart E. J., Ying Y. s., Donzell W. C., Anderson R. G. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem. 1996 Nov 15;271(46):29427–29435. doi: 10.1074/jbc.271.46.29427. [DOI] [PubMed] [Google Scholar]
  39. Song K. S., Li Shengwen, Okamoto T., Quilliam L. A., Sargiacomo M., Lisanti M. P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 1996 Apr 19;271(16):9690–9697. doi: 10.1074/jbc.271.16.9690. [DOI] [PubMed] [Google Scholar]
  40. Song K. S., Tang Z., Li S., Lisanti M. P. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions. J Biol Chem. 1997 Feb 14;272(7):4398–4403. doi: 10.1074/jbc.272.7.4398. [DOI] [PubMed] [Google Scholar]
  41. Soskic V., Nyakatura E., Roos M., Müller-Esterl W., Godovac-Zimmermann J. Correlations in palmitoylation and multiple phosphorylation of rat bradykinin B2 receptor in Chinese hamster ovary cells. J Biol Chem. 1999 Mar 26;274(13):8539–8545. doi: 10.1074/jbc.274.13.8539. [DOI] [PubMed] [Google Scholar]
  42. Uchida K., Kawakishi S. Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem. 1994 Jan 28;269(4):2405–2410. [PubMed] [Google Scholar]
  43. Uittenbogaard A., Smart E. J. Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae. J Biol Chem. 2000 Aug 18;275(33):25595–25599. doi: 10.1074/jbc.M003401200. [DOI] [PubMed] [Google Scholar]
  44. Uittenbogaard A., Ying Y., Smart E. J. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking. J Biol Chem. 1998 Mar 13;273(11):6525–6532. doi: 10.1074/jbc.273.11.6525. [DOI] [PubMed] [Google Scholar]
  45. Vepa S., Scribner W. M., Natarajan V. Activation of protein phosphorylation by oxidants in vascular endothelial cells: identification of tyrosine phosphorylation of caveolin. Free Radic Biol Med. 1997;22(1-2):25–35. doi: 10.1016/s0891-5849(96)00241-9. [DOI] [PubMed] [Google Scholar]
  46. Volonté D., Galbiati F., Pestell R. G., Lisanti M. P. Cellular stress induces the tyrosine phosphorylation of caveolin-1 (Tyr(14)) via activation of p38 mitogen-activated protein kinase and c-Src kinase. Evidence for caveolae, the actin cytoskeleton, and focal adhesions as mechanical sensors of osmotic stress. J Biol Chem. 2000 Nov 27;276(11):8094–8103. doi: 10.1074/jbc.M009245200. [DOI] [PubMed] [Google Scholar]
  47. Webb Y., Hermida-Matsumoto L., Resh M. D. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem. 2000 Jan 7;275(1):261–270. doi: 10.1074/jbc.275.1.261. [DOI] [PubMed] [Google Scholar]
  48. Wedegaertner P. B., Bourne H. R. Activation and depalmitoylation of Gs alpha. Cell. 1994 Jul 1;77(7):1063–1070. doi: 10.1016/0092-8674(94)90445-6. [DOI] [PubMed] [Google Scholar]
  49. Wedegaertner P. B., Wilson P. T., Bourne H. R. Lipid modifications of trimeric G proteins. J Biol Chem. 1995 Jan 13;270(2):503–506. doi: 10.1074/jbc.270.2.503. [DOI] [PubMed] [Google Scholar]
  50. van't Hof W., Resh M. D. Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation. Methods Enzymol. 2000;327:317–330. doi: 10.1016/s0076-6879(00)27287-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES